Skip to content
Prime Hub Studio

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Agreement Because of Information Concerns

Medical aid illustration
The proposed American financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has declined a major US healthcare agreement valued at $367m (£272m) over five years due to the United States' demand for sensitive information.

This move was revealed after a government memo from December was disclosed, indicating that President Emmerson Mnangagwa believed the deal was "skewed".

A government spokesperson later clarified that the US was requesting biological samples for scientific study and commercial purposes while was not willing to guarantee the benefits from any future treatments.

"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A medical body in Zimbabwe has urged further dialogue to reach a deal suitable to both sides so the nation's vital HIV programme can continue.

Wider Background

This rejection follows a comparable case in neighbouring Kenya, where a court suspended a related health funding agreement after concerns were raised about the security of citizens' medical information.

Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

USAID had managed aid for the US government, but Trump argued its spending was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and accountability.

Based on statements, Sixteen African countries have to date signed similar health pacts, representing over $18.3bn in new funding.

Details of the Declined Agreement

The funds for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this collaboration could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through American-funded initiatives," Tremont commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"Zimbabwe was being asked to share its biological resources and data for a long time, without any corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that shared data," his statement read.

"In essence, our country would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our citizens should a future disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining structures already established through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.

"This framework is intended to guarantee that when a country provides its data, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the funds to create them."

The government's concerns regarding the US deal "are not meant as opposition to America," he added.

"We are open to continued dialogue with our US partners on how subsequent collaboration might be structured in a manner that respects the sovereignty and dignity of both nations."

Medical Community Response

A leading public health body expressed it acknowledged the government's concerns, but suggested that talks must proceed since a large portion of the nation's Aids initiatives depended on external financing.

"Where technical issues arise, including those involving information security or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," it added.

The halted deal highlights the continuing challenges between receiving vital international aid and safeguarding a country's data in an increasingly data-driven world.

The writer

Brian Morales

Liam van der Berg is a digital strategist and creative director at Prime Hub Studio, with over a decade of experience in brand development and online presence optimization.

Prime Hub Studio

Type to search articles.